
The development comes on a day the Haryana government ordered the halting of drug manufacturing at the Sonipat unit of Maiden Pharmaceuticals, and asked it to explain within a week "many contraventions" found during a recent inspection, or face suspension or cancellation of license.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/YdHMU5L
via
IFTTT
0 comments:
Post a Comment